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Abstract
Introduction: Hyponatremia (serum sodium,135 mMol/L) is the commonest electrolyte imbalance encountered in clinical
practice. It is associated with multiple poor clinical outcomes including increased mortality, longer hospital stay, falls and
fractures. Prevalence is higher in frail patient groups, and elderly patients with fragility fractures (EPFF) are particularly
susceptible. Euvolemic hyponatremia due to syndrome of inappropriate anti-diuretic hormone (SIADH) is widely assumed to
be the commonest cause. However, little is known about the epidemiology and etiology of hyponatremia in EPFF. This
study established prevalence, incidence and etiology of hyponatremia in EPFF.
Methods: Prospective observational study of consenting adults aged $65 years admitted with a fragility fracture to a
university hospital between 7th January and 4th April 2013. Prevalence of hyponatremia on admission and incidence of
cases developing in hospital were reported. Etiology of cases of hyponatremia was determined by consensus of an expert
panel using pre-specified data collected daily.
Results: 127/212 (60%) EPFF were recruited (mean age 79 yrs, 78% female). Two participants withdrew mid-study. Of those
not recruited, 66 had incapacity to consent and 19 refused participation. Point prevalence of hyponatremia on admission
was 13.4% and a further 12.6% developed hyponatremia during admission. Hypovolemic hyponatremia was predominant
(70%). 73% of cases were multi-factorial in etiology. The commonest potentially causative factors in cases of hyponatremia
were thiazide diuretics (76%), dehydration (70%), proton pump inhibitors (70%), SIADH (27%) and mirtazapine (15%).
Conclusion: Hyponatremia is highly prevalent in EPFF, seen in 26% of cases. Dehydration and prescription of thiazide
diuretics and proton pump inhibitors were the commonest potentially causative factors, not SIADH.
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Introduction
Hyponatremia, serum sodium , 135 mMol/L, is the com-
monest electrolyte imbalance encountered in clinical practice. It is
associated with multiple poor clinical outcomes including falls,
fractures, increased length of hospital stay, institutionalisation and
mortality [1]. Prevalence is known to increase in frail patient
groups, such as elderly, hospitalised, peri-operative patients with a
fracture. Elderly patients with fragility fractures (EPFF) have
increased risk of hyponatremia as a result of degenerate
physiology, multiple co-morbidities, polypharmacy, increased risk
of dehydration due to hospitalisation and peri-operative fluid
restriction, and homeostatic stress from fracture and subsequent
surgical interventions [2–6]. eThey are also at higher risk of
complications, making this group of special clinical importance.
Hyponatremia itself may be responsible for the fracture [7].
Reports of the prevalence of hyponatremia at admission in EPFF
vary widely between 2.8%–26.5%, while 2.6–5.5% develop
hyponatremia in the post-operative period [3–5,8,9]. Hyponatre-
mia occurs due to disruption of sodium and water homeostasis,
normally maintained by complex multi-system physiological
mechanisms [1]. Consequently, there are numerous potential
underlying causes of hyponatremia, spanning a broad spectrum of
diseases, pharmacotherapy and pathophysiological variants each
with different treatment requirements (see Figure 1) [2].
When very acute or severe, hyponatremia may present with
neurological symptoms which can result in serious complications
e.g. hyponatremic encephalopathy, non-cardiogenic pulmonary
oedema, seizures, coma, death [2,10–13]. However, 75–80% of
cases of hyponatremia are mild and chronic (i.e. serum sodium
130–134 mMol/L, occurring over .24 hours) and typically
devoid of obvious neurological symptoms [1,2,14]. As a result,
chronic mild hyponatremia is frequently considered asymptomatic
despite being strongly associated with major geriatric conditions
and multi-organ pathological changes. These include abnormal
gait patterns, falls, fractures, cognitive impairment, bone demin-
eralisation, longer hospital stay, institutionalisation and increased
mortality [2,5,6,9,12,15–19]. Despite this, older people may be at
lower risk of hyponatremic encephalopathy and subsequent
complications of acute severe hyponatremia [20], where female
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gender, hypoxia and liver dyfunction are associated with poorer
prognosis [21]. eWhether hyponatremia is an independent
predictor of patient outcomes or a marker of disease severity is
controversial [2]. Nevertheless, it is very treatable, so its
association with multiple poor clinical outcomes is important.
Clinical management of hyponatremia is based on diagnosing
and treating the underlying cause(s) and restoring salt and water
balance (see Figure 2) [1]. However, accurate determination of
etiology of hyponatremia is notoriously challenging [22]. The best
available method to elucidate causes of hyponatremia is by expert
panel consensus. Diagnosis depends crucially on accurate assess-
ment of volemic status which is difficult to determine with
certainty, especially in older individuals for whom there is
currently no reliable biomarker of hydration [2,20]. Euvolemic
hyponatremia due to the syndrome of inappropriate anti-diuretic
hormone (SIADH) is widely assumed to be the commonest cause
[17]. However, SIADH may be over-diagnosed as a result of
diagnostic difficulties, particularly in dehydrated older people
[2,23]. Subsequently, patients may be subject to serious clinical
consequences as the management of SIADH (fluid restriction) is
the exact opposite of the management of dehydration (vigorous
fluid replacement). ee
SIADH is a reportedly common cause of hyponatremia in EPFF
along with excess hypotonic fluid, diuretic and antidepressant
therapies [3,5,8–10], but the process of attribution of causation of
hyponatremia in these studies did not include expert review or any
quality assurance process. Our aim was to undertake the most
detailed study to date of the etiology of hyponatremia in EPFF and
report its prevalence and incidence.
Materials and Methods
We carried out a prospective observational study of all adults
aged 65 years or over admitted with a fragility fracture to a
university teaching hospital from 7th January – 4th April 2013.
Fragility fractures were defined as those occurring either without
trauma or due to low energy trauma, equivalent to a fall from
standing height or less than one metre. Anonymous baseline data
(age, sex, fracture site and admission serum sodium) of all
identified EPFF were recorded. Adults with incapacity were
excluded from recruitment. Capacity to consent was assessed by
the attending clinical team in accordance with the Adults with
Incapacity (Scotland) Act 2000. Participants were recruited from
acute orthopaedic trauma wards and a geriatric assessment unit.
Clinical data were collected daily until discharge, from patient
interview, medical and nursing notes, observation and fluid
balance charts and laboratory computer systems by a single
investigator (KC). Medication data were obtained by reconciling
patient and/or carer histories, and primary and secondary care
records. Also, clinical examination of volemic status was
performed daily by the investigator. This involved measurement
of skin turgor, capillary refill time, mouth moistness, axillary
Figure 1. Hyponatremia diagnostic algorithm. Adapted from Soiza et al. [1]
doi:10.1371/journal.pone.0088272.g001
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moistness, jugular venous distension, peripheral oedema and
overall impression (signs selected based on previous research
recommendations) [22]. Examination was carried out by one
investigator to increase reliability of findings, maximise consistency
and exclude effects of inter-observer variability. An initial two
week training period of examination of volemic status, under
supervision of the principal investigator (RLS), was undertaken to
help ensure quality and consistency.
Cases of hyponatremia were defined as any serum sodium
measurement ,135 mmol/L. An expert panel, consisting of two
consultant geriatricians with special interest in hyponatremia (RLS
and GEH) and one consultant orthopaedic surgeon (JDH)
reviewed and determined etiology of each case of hyponatremia.
The panel did not examine patients themselves but instead
retrospectively reviewed each case of hyponatremia relying on the
detailed daily prospectively-collected data and clinical examina-
tion findings provided by the investigator. This included all clinical
information required to determine underlying cause(s) of hypona-
tremia - history, medications, detailed daily examination, fluid
intake and output charts and laboratory results. Collectively, the
expert panel used a diagnostic algorithm (Figure 1) to determine
underlying cause(s) of hyponatremia.
Ethical approval was obtained from the Scotland A Research
Ethics Committee (Ref 12/SS/0209). The original protocol
submitted to the Committee had provision for the inclusion of
adults with incapacity to consent but the Committee’s approval
was dependent on their exclusion. The Committee’s recommen-
dations were fully incorporated into the final study design and final
approval was obtained from the Committee Scientific Advisor.
The prevalence of hyponatremia upon admission and the
incidence of cases developing in hospital were calculated. For
incident cases, we recorded whether the hyponatremia was pre- or
post-operative. The proportion of participants with known
hyponatremia prior to their fracture was calculated by obtaining
the last available serum sodium for each patient prior to their
admission to hospital. The laboratory is the only public health
service laboratory covering the study population so it was unlikely
that patients had more recent investigations elsewhere. Prevalence
of hyponatremia at discharge was calculated according to the last
available serum sodium measurement prior to discharge.
Independent-T tests or Mann-Whitney U tests were used as
appropriate. Pearson chi-squared and Fisher’s exact tests were
calculated to compare proportions across groups. Statistical
Package for Social Sciences (SPSS) version 20.0 was used to
perform all analyses. Statistical significance was assumed where
p,0.05.
Results
Recruitment, participant information and data collection
There were 214 EPFF identified and 127 were recruited into the
study (see Figure 2). Those not recruited had incapacity to consent
(N= 66), declined participation (N= 19), or agreed but were later
excluded when the original diagnosis of fragility fracture was
excluded (N=2). There were no statistically significant differences
between participants and those who were eligible but declined
participation (see Table 1). However, compared to participants,
adults with incapacity were on average seven years older (p,
0.001) and had different proportions of fractures site, with hip
fractures composing n= 47 (71.2%) of fractures compared to
n= 67 (52.8%) in participants (p = 0.017). The characteristics and
outcomes of the 127 participants are detailed in Tables 2 and 3,
categorised according to natremic state.
Two (1.6%) participants voluntarily withdrew mid-study, but all
others completed the study (n= 125). Data completion was 86%
overall as daily clinical examination was not always appropriate or
possible (e.g. patient declining on a given day or in critical
condition). Although all volunteers had at least one serum sodium
and at least 24 hours of fluid balance measurements, serum
sodium measurements were available in 44% of the total patient-
days in hospital. Complete fluid balance charts were available for
50% of the total days spent in hospital by participants. Medication
data were complete for all cases. None of the hyponatremic
participants had urine sodium concentration measured.
Epidemiology of hyponatremia
Prevalence of hyponatremia upon admission in all identified
EPFF was 14.2%. In recruited volunteers, the prevalence of known
hyponatremia prior to their fracture was 10.2%. Point prevalence
at admission in the recruited group was 13.4%. There were 16
incident cases of hyponatremia developing in hospital (12.6%). Of
these incident cases, four (25%) developed pre-operatively, eleven
(68.3%) post operatively (one patient died), and one (6.3%) in a
patient who was deemed unfit for surgery. The prevalence of
known hyponatremia at discharge was 19%. Thus, hyponatremia
was detected in 33 participants (26%) and mild hyponatremia (Na
130–134 mmol/L) was predominant (N= 25, 75.8%).
Etiology of hyponatremia
Hypovolemic hyponatremia was present in 23 cases (69.7%), 9
cases were euvolemic (27.3%) and one case hypervolemic (3%).
Etiology was multifactorial in 24/33 cases (72.7%)e. The identified
underlying causes and contributory factors are displayed in
Table 4. There were no significant differences in causes of
hyponatremia between those developing pre- or post-admission.
Figure 2. Participant recruitment flow chart.
doi:10.1371/journal.pone.0088272.g002
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Discussion
The findings demonstrate that hyponatremia in EPFF is highly
prevalent, occurring in 33/127 cases (26%). Although it had
previously been assumed that euvolemic hyponatremia is the
commonest type, this study shows that hypovolemic hyponatremia
is predominant in EPFF.
The 13.4% point prevalence of hyponatremia upon hospital
admission, is within the range of recently reported figures for
EPFF, 2.8–26.5% [5,8,9,24–26]. Our result is almost identical to
that of Gankam Kengne et al. who report 13.1% prevalence in
EPFF, studying a population with similar proportions of hip and
femoral fractures (55%) in a larger scale retrospective study [5].
The 10.2% prevalence of hyponatremia prior to fracture in this
study is higher than the 8% prevalence reported in ambulatory
patients .60 years and 5.7% in very old non-hospitalised
individuals [4,27]. This may reflect the underlying frailty of those
that go on to sustain fragility fractures but is also consistent with
the theory that some fractures may be attributable to hyponatre-
mia [7,16]. The 12.6% incidence of hyponatremia developing in
hospital reported here is significantly higher than previous
accounts in EPFF, which range from 2.6 to 5.5% [3,8,24,28].
However, unlike previous authors, we reported cases of hypona-
tremia developing at any stage in hospital rather than solely in the
post-operative period. The high incidence of new hyponatremia
has important implications for patient welfare as patients who
develop hyponatremia in hospital reportedly fare worse than those
who are hyponatremic on admission [6,29,30]. The prevalence of
hyponatremia at discharge was 19%. There are few data in the
current literature to compare our figure with. However, it appears
common practice not to treat hyponatremia, particularly when
mild and chronic, so the prevalence of hyponatremia at discharge
is presumably high [5,31,32]. This implies that clinician awareness
of the potential dangers of hyponatremia is low. Gankam Kengne
et al. reported that four of eighteen EPFF discharged with
hyponatremia had recurrent falls and fractures [5]. In common
with comparable studies, most cases of hyponatremia in this study
were mild and therefore at risk of being unidentified or ignored
[16,25,33].
Regarding etiology, hyponatremia was multi-factorial in 72.7%
of cases in this study. This is consistent with previous reports that
51.3% and 75.3% of hyponatremia in elderly patients is
multifactorial, though both reports concerned severe hyponatre-
mia [18,19]. However, our findings contrast with previous studies
that report that SIADH is the commonest cause of hyponatremia
in other patient settings [18,19]. SIADH was associated with
27.3% of cases of hyponatremia in this study. In a most similar
cohort of EPFF, 37% of cases of hyponatremia were attributed to
SIADH on discharge diagnosis, all of which were idiopathic [5].
Although SIADH may have no obvious underlying cause, this
raises the possibility that SIADH was over-diagnosed [21]. The
findings of our study suggest that SIADH is not the commonest
cause of hyponatremia in EPFF and that causes related to
hypovolemia are more frequent.
Thiazide diuretic therapy (bendroflumethiazide in all instances)
was a causative factor in 75.8% of cases of hyponatremia. The
high prevalence is greater than that reported in any other series,
but is consistent with recent findings that thiazide diuretic therapy
is an increasingly important cause [34–35]. Gankam Kengne et al.
reported diuretics were associated with 35% of cases of
hyponatremia in EPFF [5]. Hoorn et al. observed a higher pre-
scription frequency in hyponatremic EPFF compared to normo-
natremic controls [33]. In our study, bendroflumethiazide therapy
was three times more commonly prescribed in hyponatremic
Table 1. Subgroup analysis of baseline data.
Participants Non-participants P value*
Adults with
incapacity P value**
Number of individuals (N) 127 19 66
Age (years)
Mean (6 SD) 79 (68) 77 (69) 0.438 86 (67) ,0.001
Range 65–98 65–93 66–101
Female sex, % (N) 78.0 (99) 89.5 (17) 0.365 69.7 (46) 0.223
Fracture site, % (N) 0.676 0.017
Hip 52.0 (66) 36.8 (7) 69.7 (46)
Hip & upper limb 0.8 (1) 0 1.5 (1)
Other lower limb 22.0 (28) 31.6 (6) 7.6 (5)
Other lower & upper limb 0.8 (1) 0 0
Upper limb 19.7 (25) 26.3 (5) 10.6 (7)
Pelvic and upper limb 0 0 1.5 (1)
Pelvic 3.1 (4) 5.3 (1) 6.1 (4)
Vertebrae 1.6 (2) 0 3.3 (2)
Admission serum sodium (mMol/L)
Mean (6 SD) 138 (64) 138 (65) 0.556 139 (64) 0.172
Range 123–146 128–143 124–147
Prevalence of hyponatremia on
admission, % (N)
13.4 (17) 26.3 (5) 0.16 12.1 (8) 0.827
*participants v non-participants.
**participants v adults with incapacity.
doi:10.1371/journal.pone.0088272.t001
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EPFF (21.2%) than in normonatremic EPFF (7.4%) (p = 0.049).
This is an important finding given the high prevalence of
hypertension in elderly people and the widespread prescribing of
thiazide diuretics [34,35].
Dehydration was associated with 69.7% of hyponatremia,
which is in keeping with our previous proposition that many
hyponatremic older individuals have appropriate ADH secretion
and are, in fact, inadequately hydrated [21]. Dehydration was the
result of over-use or incorrect use of diuretics, or inadequate fluid
Table 2. Participant characteristics.
Characteristic Normonatremic participants Hyponatremic participants P value
Number (N) 94 33
Age (years)
Mean (6 SD) 78 (68) 81 (67) 0.083
Range 65–97 69–98
Female sex, % (N) 76.6 (72) 81.8 (27) 0.078
Previous residence, % (N)
Own home 85.1 (80) 78.8 (26) 0.390
Sheltered housing 14.9 (14) 12.1 (4)
Care home 0 6.1 (2)
Care of the elderly ward 0 3.0 (1)
Number of co-morbidities
Mean (6 SD) 4 (62) 5 (63) 0.222
Range 0–9 0–11
Number of co-morbidities that cause hyponatremia (N)
Mean (6 SD) 1 (61) 1 (61) 0.855
Range 0–3 0–4
% of participants with at least one co-morbidity that causes
hyponatremia (N)
60.6 (57) 54.5 (18) 0.681
Number of medications (N)
Mean (6 SD) 5 (64) 6 (63) 0.294
Range 0–15 0–15
% of participants on at least one medication that causes
hyponatremia (N)
64.9 (61) 72.7 (24) 0.52
Fracture site, % (N) 0.115
Hip 50.0 (47) 57.6 (19)
Hip and upper limb 1.1 (1) 0
Other lower limb 24.5 (23) 15.2 (5)
Other lower limb and upper limb 0 3.0 (1)
Upper limb 21.3 (20) 15.2 (5)
Pelvic 3.3 (3) 3.0 (1)
Vertebrae 0 6.1 (2)
Time from fracture to hospital admission (days)
Median 0 0 0.581
Interquartile range 0–1 0–1.5
Serum sodium prior to admission (mMol/L)
Mean (6 SD) 140 (62) 136 (65) ,0.001
Range 133–145 127–144
Serum sodium on admission (mMol/L)
Mean (6 SD) 139 (62) 134 (64) ,0.001
Range 135–146 127–144
Prevalence of hyponatremia, % (N)
Prior to admission* 3.2 (3) 30.3 (10) ,0.001
On admission 0 51.5 (17) ,0.001
*According to last serum sodium available prior to admission.
doi:10.1371/journal.pone.0088272.t002
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intake or replacement, or a combination of these. Although
inadequate fluid and electrolyte management in elderly surgical
patients is not a new concern, the prevalence and importance of
dehydration in hyponatremia and EPFF is relatively unreported.
Absence of reports may stem from the frequent retrospective
methodology approaches, reliant on clinical documentation which
often lack any record of hydrational state [32]. Given the high
prevalence of co-morbidities and polypharmacy in EPFF, cases of
hyponatremia caused by dehydration may be misattributed to
other causes. Thus dehydration, arguably the simplest and most
readily treatable etiology of hyponatremia, could be frequently
over-looked and underdiagnosed. This study shows it is a major
cause of hyponatremia in EPFF.
Proton pump inhibitor (PPI) therapy (omeprazole in all cases in
our study) was associated with 69.7% of cases of hyponatremia. To
our knowledge we are the first group to present this finding in
EPFF. Reports of omeprazole induced hyponatremia are infre-
quent and our finding may simply reflect the very high prevalence
of PPI prescribing in older hospitalised patients [36]. The
prevalence of PPI therapy among hyponatremic patients was
42.4% compared to 35.1% in normonatremic patients (p = 0.51).
Another possibility is that few cases of hyponatremia are solely
attributable to PPIs but hyponatremia in EPFF is predominantly
multifactorial [37]. Rosholm et al. report a lower mean serum
sodium in very old non-hospitalised individuals prescribed
omeprazole compared to controls and emphasise the role of
degenerative physiology in adverse drug reactions [27]. Consid-
ering the likelihood of degenerative physiology in EPFF and the
physiological stress in the post-fracture and peri-operative period,
our finding that omeprazole may be a significant contributor to
hyponatremia in EPFF is an important one that merits further
study.
Antidepressants were commonly associated with hyponatremia
in our study. The commonest in our cohort (15.2% of cases) was
mirtazapine. Sertraline, and amitryptiline were both associated
Table 3. Outcomes in patients with and without hyponatremia.
Characteristic Normonatremic participants Hyponatremic participants P value
Number (N) 94 33
Surgical management, % (N) 76.6 (72) 81.8 (27) 0.631
Time to surgery from admission (days)
Mean (6 SD) 1.8 (61.7) 3.0 (63.0) 0.014
Range 0–7 0–10
Patient deaths, % (N) 2.1 (2) 3.0 (1) 1
Barthel index at discharge
Median 60 57.5 0.918
Interquartile range 45–75 48.75–72.5
Decline in Barthel index from admission to discharge
Median 30 30 0.792
Interquartile range 20–45 15–45
Length of hospital stay (days)
Mean (6 SD) 6.8 (65.0) 10.3 (68.4) 0.006
Range 0–27 1–45
Discharge destination, % (N) 0.51
Previous residence 29.8 (28) 21.2 (7)
Relative’s residence 4.3 (4) 0
Orthopaedic rehabilitation 55.3 (52) 72.7 (24)
Care of the elderly ward 3.2 (3) 3.0 (1)
Other medical specialty ward 2.1 (2) 0
doi:10.1371/journal.pone.0088272.t003
Table 4. Etiologies of case of hyponatremia.
Etiology % of cases associated (N)
Bendroflumethiazide 75.8 (25)
Dehydration 69.7 (23)
Proton pump inhibitors 69.7 (23)
Syndrome of inappropriate antidiuretic
hormone
27.3 (9)
Mirtazapine 15.2 (5)
Glucocorticoid deficiency 6.1 (2)
Reset osmostat 6.1 (2)
Liver cirrhosis 6.1 (2)
Heart failure 6.1 (2)
Furosemide 6.1 (2)
Sertraline 3.0 (1)
Fluid overload 3.0 (1)
Butetamide 3.0 (1)
Olanzapine 3.0 (1)
Amitriptyline 3.0 (1)
Chronic kidney disease 3.0 (1)
Non-steroidal anti-inflammatory drugs 3.0 (1)
Phenobarbitone 3.0 (1)
doi:10.1371/journal.pone.0088272.t004
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with a single case each (3%). Our findings are in line with those of
other studies. Studying large bone fractures, Sandu et al. report
that 24.2% of hyponatremic patients were prescribed antidepres-
sants (75% selective serotonin reuptake inhibitors (SSRIs) and
25% mirtazapine), compared to no antidepressant prescriptions in
a control group with no fracture [25]. Studying EPFF, Gankam
Kengne et al. similarly report that 17% of cases of hyponatremia
were attributable to SSRIs. Previous studies present conflicting
evidence between specific antidepressants and the risk of
hyponatremia, and this may simply reflect differences in prescrib-
ing patterns [38,39]. Movig et al. report that, in elderly people,
concomitant diuretic and SSRI therapy incurs a 13.5 increased
odds ratio of developing hyponatremia compared to SSRI therapy
alone [39]. The frequent concomitant prescribing of both these
drug classes in elderly patients makes this an important
observation, especially considering the results of our study.
The remaining etiologies encountered in this study were not
surprising and were representative of a general multi-morbid
elderly patient cohort. Two independent groups reported that all
elderly orthopedic patients becoming hyponatremic post-opera-
tively received hypotonic fluids, mostly in the form of dextrose
[3,40]. We did not find this in our study as hypotonic study was
hardly ever prescribed (only to two patients that developed
hyponatremia and no more than 1000 mls each in total).
However, fluid overload was associated with one case of
hyponatremia where the patient had cardiac failure (3%). This
may reflect different practices in different centres or may reflect
changes in practice with time.
We did not set out to measure outcomes in this study, but the
mean length of time from admission to surgery was higher in
hyponatremic participants (3 days) compared to normonatremic
participants (1.8 days), a 66.7% increase (p = 0.014). This delay is a
potential risk factor for development of hyponatremia and suggests
patients with admission or pre-operative hyponatremia may have
more complicated co-morbidities or fractures and therefore
require a pre-operative preparatory period. It also suggests that
a delayed time to surgery increases the risk of hyponatremia,
potentially by dehydration or inappropriate fluid and electrolyte
management. Hyponatremic participants had a 3.5 day longer
mean length of hospital stay, compared to normonatremic
participants, a 51.5% increase (p = 0.006). Delayed discharge in
hyponatremic patients may be caused by attempts to correct the
hyponatremia in hospital but it is clear from our study that this is
not the case as asymptomatic hyponatremia was usually left
untreated. More plausible alternative explanations are that the
hyponatremia is a marker of dyshomeostasis or comorbidities
which delay discharge, or directly causes subtle cognitive or
functional impairments that complicate discharge.
Our study has some important limitations. The observational
design did not permit the investigating team to request clinical
tests. This was particularly relevant because the clinical manage-
ment of hyponatremia was frequently sub-optimal and important
clinical investigations were not always carried out. Therefore data
were missing in some instances.
In these instances the expert panel relied on avaliable clinical
information and the over-all clinical picture of each case as it
transpired i.e. changes in serum sodium compared to iatrogenic
interventions. This same limitation has previously been encoun-
tered by various other groups [5,31,32]. Since patients did not
have daily serum sodium measurements, it is likely that our report
may underestimate the true incidence of hyponatremia in EPFF.
The same issue also complicated the already challenging task of
diagnosing etiology of hyponatremia in elderly patients. Although
expert panel consensus decision represents the best available
method to elucidate causes, there remains considerable uncertain-
ty with regard to diagnosis, especially where information is limited.
This is particularly pertinent in relation to diagnosing SIADH,
which strictly requires urine sodium concentration measurement
and other investigations that are frequently missed [41]. Whilst
these are limitations of this study they reflect the reality of
inadequate awareness and management of hyponatremia in
clinical practice, predisposing these already frail patients to
worsened clinical outcomes.
A second limitation is the relatively small sample size of this
single centred study meaning that the results may be subject to
selection and sampling bias. Moreover adults with incapacity, who
compose a significant proportion of EPFF, were excluded from this
study as dictated by the ethics committee. Given the independent
association between hyponatremia and age, excluding this frail
patient cohort at highest risk of hyponatremia (mean age 7 years
older than participants), compromises the generalisability of our
findings [2]. Furthermore, considering the 12.1% prevalence of
hyponatremia among the adults with incapacity identified in this
study and the association between hyponatremia and cognitive
impairment, including this patient subset in future research ought
to be routine. Indeed, hyponatremia may be the precipitant cause
of incapacity and so these frailer patients may arguably benefit
most from improved understanding of etiology of hyponatremia in
EPFF. A third limitation is the possibility of ascertainment bias as
individual members of the expert panel may have their own
preconceptions on common and uncommon causes. However,
discussion amongst the three experts and the use of the diagnostic
algorithm served to minimise ascertainment bias, if any was
present.
Despite these limitations this study makes a significant
contribution to the current understanding of hyponatremia in
EPFF. The prospective study design is an improvement over
published retrospective comparators. Unlike other published series
that typically rely on diagnoses made by clinicians inexpert in
hyponatremia, or on retrospective analysis of databases using
discharge codes, the present study collected data prospectively that
were then reviewed by an expert panel. The attention paid to data
regarding volemic state in our study far surpasses previous work.
Despite the aforementioned limitations, the involvement of two
consultant geriatricians with special interest in hyponatremia,
makes this report the most accurate account of etiology of
hyponatremia in EPFF to date. The expertise of these individuals
not only provided quality assurance of etiology reported for these
complex patients, but enabled identification of the likeliest
diagnoses in cases lacking all data.
In summary, hyponatremia is highly prevalent in EPFF. This
study shows that etiology of hyponatremia in EPFF is frequently
multifactorial, mostly drug induced and associated with inade-
quate fluid replacement therapy. We found SIADH was associated
with under a third of cases. This suggests that prevalence and
incidence of hyponatremia in EPFF could potentially be reduced
by appropriate fluid replacement therapy and careful prescribing.
It would be important to confirm this in a further larger, multi-
centre study. Although it remains unclear if targeting hyponatre-
mia itself would improve patient outcomes, such interventions
have great potential to decrease falls and fractures in older people
and generally improve prognosis in EPFF.
Author Contributions
Conceived and designed the experiments: RLS. Performed the experi-
ments: KC GEH JDH RLS. Analyzed the data: KC RLS. Contributed
reagents/materials/analysis tools: JDH RLS. Wrote the paper: KC GEH
JDH RLS.
Hyponatremia in Fragility Fracture
PLOS ONE | www.plosone.org 7 February 2014 | Volume 9 | Issue 2 | e88272
References
1. Soiza RL, Hoyle GE, Chua MPW (2008) Electrolyte and salt disturbances in
older people: causes, management and implications. Rev Clin Gerontol 18:143–
158.
2. Soiza RL, Talbot HSC (2011) Management of hyponatremia in older people:
old threats and new opportunities. Ther Adv Drug Safety 2:9–17.
3. Tambe AA, Hill R, Livesley PJ (2003) Post-operative hyponatremia in
orthopaedic injury. Injury 34:253–255.
4. Upadhyay A, Jaber BL, Madias NE (2006) Incidence and Prevalence of
Hyponatremia. Am J Med 119:S30–S35.
5. Gankam Kengne F, Andres C, Sattar L, Melot C, Decaux G (2008) Mild
hyponatremia and risk of fracture in the ambulatory elderly. QJM 101:583–588.
6. Chua M, Hoyle GE, Soiza RL (2007) Prognostic implications of hyponatremia
in elderly hospitalized patients. Arch Gerontol Geriatr 45:253–258.
7. Ayus JC, Arieff AI (1999) Chronic hyponatremic encephalopathy in postmen-
opausal women: association of therapies with morbidity and mortality. JAMA
281:2299–2304.
8. Beloosesky Y, Hershkovitz A, Solovey B, Salai M, Weiss A. (2011) Hip fracture
post-operation dysnatremia and Na+-courses in different cognitive and
functional patient groups. Arch Gerontol Geriatr 53:179–182.
9. Tolouian R, Alhamad T, Farazmand M, Mulla ZD (2012) The correlation of
hip fracture and hyponatremia in the elderly. J Nephrol 25:789–793.
10. Ayus JC, Krothapalli RK, Arieff AI (1987) Treatment of symptomatic
hyponatremia and its relation to brain damage. N Engl J Med 317:1190–1195.
11. Ayus JC, Varon J, Arieff AI (2000) Hyponatremia, cerebral edema, and
noncardiogenic pulmonary edema in marathan runners. Ann Intern Med
132:711–714.
12. Ayus JC, Moritz ML (2010) Bone disease as a new complication of
hyponatremia: moving beyond brain injury. Clin J Am Soc Nephrol 5:167–168.
13. Ayus JC, Achinger SG, Arieff A (2008) Brain cell volume in hyponatremia: role
of sex, age, vasopressin, and hypoxia. Am J Physiol Renal Physiol 295:F619–
F624.
14. Boscoe A, Paramore C, Verbalis JG (2006) Cost of illness of hyponatremia in the
United States. Cost Eff Resour Alloc 4:10.
15. Barsony J, Manigrasso MB, Xu Q, Tam H, Verbalis JG (2013) Chronic
hyponatremia exacerbates multiple manifestations of senescence in male rats.
Age 35:271–288.
16. Verbalis JG, Barsony J, Sugimura Y, Tian Y, Adams DJ, et al. (2010)
Hyponatremia-induced osteoporosis. J Bone Mineral Res 25:554–563.
17. Renneboog B, Musch W, Vandemergel X, Manto MU, Decaux G (2006) Mild
Chronic Hyponatremia Is Associated With Falls, Unsteadiness, and Attention
Deficits. Am J Med 119:71.e1–71.e8.
18. Shapiro DS, Sonnenblick M, Galperin I, Melkonyan L, Munter G (2010) Severe
hyponatremia in elderly hospitalized patients: Prevalence, aetiology and
outcome. Intern Med J 40:574–580.
19. Clayton JA, Le Jeune IR, Hall IP (2006) Severe hyponatremia in medical in-
patients: aetiology, assessment and outcome. QJM 99:505–511.
20. Ayus JC, Negri AL, Kalantar-Zadch K, Moritz ML (2012) Is chronic
hyponatremia a novel risk fsctor for hip fracture in the elderly? Nephrol Dial
Transplant 27:3275–3731
21. Ayus JC, Wheeler JM, Arieff AI (1992) Postoperative hyponatraemic
encephalopathy in menstruant women. Ann Intern Med 117:891–897.
22. Hoyle GE, Chua M, Soiza RL (2011) Volaemic assessment of the elderly
hyponatremic patient: reliability of clinical assessment and validation of
bioelectrical impedance analysis. QJM 104:35–39.
23. Soiza RL, Hoyle GE (2011) Syndrome of appropriate antidiuretic hormone:
difficulties with diagnosing syndrome of inappropriate antidiuretic hormone in
older people. Intern Med J 41:295.
24. McPherson E, Dunsmuir RA (2002) Hyponatremia in hip fracture patients.
Scott Med J 47:115–116.
25. Sandhu HS, Gilles E, DeVita MV, Panagopoulos G, Michelis MF (2009)
Hyponatremia associated with large-bone fracture in elderly patients. Int Urol
Nephrol 41:733–737.
26. Kinsella S, Moran S, Sullivan MO, Molloy MGM, Eustace JA (2010)
Hyponatremia Independent of Osteoporosis is Associated with Fracture
Occurrence. Clin J Am Soc Nephrol 5:275–280.
27. Rosholm J, Nybo H, Andersen Ranberg K, Himmelstrup B, Skjelbo E, et al.
(2002) Hyponatremia in Very Old Nonhospitalised People: Association with
Drug Use. Drugs Aging 19:685–693.
28. Incalzi RA, Gemma A, Capparella O, Terranova L, Sanguinetti C, et al. (1993)
Post-operative electrolyte imbalance: Its incidence and prognostic implications
for elderly orthopaedic patients. Age Ageing 22:325–331.
29. Gill G, Huda B, Boyd A, Skagen K, Wile D, et al. (2006) Characteristics and
mortality of severe hyponatremia - a hospital-based study. Clin Endocrinol (Oxf)
65:246–249.
30. Wald RCM, Jaber BL, Price LL, Upadhyay A, Madias NE (2010) Impact of
Hospital-Associated Hyponatremia on Selected Outcomes. Arch Intern Med
170:294–302.
31. Gosch M, Joosten-Gstrein B, Heppner HJ, Lechleitner M (2012) Hyponatremia
in geriatric inhospital patients: effects on results of a comprehensive geriatric
assessment. Gerontology 58:430–440.
32. Saeed BO, Beaumont D, Handley GH, Weaver JU (2002) Severe hyponatremia:
investigation and management in a district general hospital. J Clin Pathol
55:893–896.
33. Hoorn EJ, Rivadeneira F, van Meurs JB, Ziere G, Stricker BH, et al. (2011) Mild
hyponatremia as a risk factor for fractures: the Rotterdam Study. J Bone Miner
Res 26:1822–1828.
34. Mann SJ (2008) The silent epidemic of thiazide-induced hyponatremia. J Clin
Hypertens (Greenwich) 10:477–484.
35. Clayton JA, Rodgers S, Blakey J, Avery A, Hall IP (2006) Thiazide diuretic
prescription and electrolyte abnormalities in primary care. Br J Clin Pharmacol
61:87–95.
36. Hamzat H, Sun H, Ford JC, MacLeod J, Soiza RL, et al. (2012) Inappropriate
Prescribing of Proton Pump Inhibitors in Older Patients Effects of an
Educational Strategy. Drugs Aging 29:681–690.
37. Durst RY, Pipek R, Levy Y (1994) Hyponatremia caused by omeprazole
treatment. Am J Med 97:400–401.
38. Wilkinson TJ, Begg EJ, Winter AC, Sainsbury R (1999) Incidence and risk
factors for hyponatremia following treatment with fluoxetine or paroxetine in
elderly people. Br J Clin Pharmacol 47:211–217.
39. Movig KLL, Leufkens HGM, Lenderink AW, Van Den Akker VGA,
Hodiamont PPG, et al. (2002) Association between antidepressant drug use
and hyponatremia: a case-control study. Br J Clin Pharmacol 53:363–369.
40. Chung HM, Kluge R, Schrier RW, Anderson RJ (1986) Postoperative
Hyponatremia. A Prospective Study. Surv Anesthesiol 30:292.
41. Verbalis JG, Goldsmith SR, Greenberg A, Schrier RW, Sterns RH (2007)
Hyponatremia Treatment Guidelines 2007: Expert Panel Recommendations.
Am J Med 120:S1–S21.
Hyponatremia in Fragility Fracture
PLOS ONE | www.plosone.org 8 February 2014 | Volume 9 | Issue 2 | e88272
